These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9187327)

  • 1. NMDA and non-NMDA receptor antagonists protect against excitotoxic injury in the rat spinal cord.
    Liu S; Ruenes GL; Yezierski RP
    Brain Res; 1997 May; 756(1-2):160-7. PubMed ID: 9187327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are NMDA or AMPA/kainate receptor antagonists more efficacious in the delayed treatment of excitotoxic neuronal injury?
    Prehn JH; Lippert K; Krieglstein J
    Eur J Pharmacol; 1995 Jan; 292(2):179-89. PubMed ID: 7720791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of kainic acid/AMPA and metabotropic glutamate receptors in the regulation of opioid mRNA expression and the onset of pain-related behavior following excitotoxic spinal cord injury.
    Abraham KE; McGinty JF; Brewer KL
    Neuroscience; 2001; 104(3):863-74. PubMed ID: 11440816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures.
    Kristensen BW; Noraberg J; Zimmer J
    Brain Res; 2001 Oct; 917(1):21-44. PubMed ID: 11602227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excitotoxic effects of non-NMDA receptor agonists in organotypic corticostriatal slice cultures.
    Kristensen BW; Noraberg J; Jakobsen B; Gramsbergen JB; Ebert B; Zimmer J
    Brain Res; 1999 Sep; 841(1-2):143-59. PubMed ID: 10546997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.
    Xue D; Huang ZG; Barnes K; Lesiuk HJ; Smith KE; Buchan AM
    J Cereb Blood Flow Metab; 1994 Mar; 14(2):251-61. PubMed ID: 7509339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of non-NMDA subtypes of glutamate receptor in the neonatal rat hemisected spinal cord in vitro.
    Zeman S; Lodge D
    Br J Pharmacol; 1992 Jun; 106(2):367-72. PubMed ID: 1382781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors.
    Wrathall JR; Teng YD; Choiniere D
    Exp Neurol; 1996 Jan; 137(1):119-26. PubMed ID: 8566203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate.
    Greene JG; Greenamyre JT
    J Neurochem; 1995 Jan; 64(1):430-6. PubMed ID: 7528265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective use of N-methyl-D-aspartate receptor antagonists as a spinoplegia against excitatory amino acid neurotoxicity.
    Cho Y; Ueda T; Mori A; Shimizu H; Haga Y; Yozu R
    J Vasc Surg; 2005 Oct; 42(4):765-71. PubMed ID: 16242566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of intravenous NBQX and GYKI 53655 as AMPA antagonists in the rat spinal cord.
    Chizh BA; Cumberbatch MJ; Headley PM
    Br J Pharmacol; 1994 Jul; 112(3):843-6. PubMed ID: 7522860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic excitatory amino acid receptor antagonists of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats.
    Xu XJ; Hao JX; Seiger A; Wiesenfeld-Hallin Z
    J Pharmacol Exp Ther; 1993 Oct; 267(1):140-4. PubMed ID: 8229741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia.
    Gill R
    Cerebrovasc Brain Metab Rev; 1994; 6(3):225-56. PubMed ID: 7529037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMDA and AMPA receptors evoke transmitter release from noradrenergic axon terminals in the rat spinal cord.
    Sundström E; Holmberg L; Souverbie F
    Neurochem Res; 1998 Dec; 23(12):1501-7. PubMed ID: 9821153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMDA and not non-NMDA receptor antagonists are protective against seizures induced by homocysteine in neonatal rats.
    Folbergrová J
    Exp Neurol; 1994 Dec; 130(2):344-50. PubMed ID: 7867764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of spinal NMDA and AMPA receptors in episodic hypertension in conscious spinal rats.
    Maiorov DN; Krenz NR; Krassioukov AV; Weaver LC
    Am J Physiol; 1997 Sep; 273(3 Pt 2):H1266-74. PubMed ID: 9321815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation of NMDA and non-NMDA excitatory amino acid receptors in the mediation of spinal reflex potentials in rats: an in vivo study.
    Farkas S; Ono H
    Br J Pharmacol; 1995 Mar; 114(6):1193-205. PubMed ID: 7620709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h.
    Sheardown MJ; Suzdak PD; Nordholm L
    Eur J Pharmacol; 1993 Jun; 236(3):347-53. PubMed ID: 7689464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive effects of NMDA and non-NMDA receptor antagonists in the tail flick test in mice.
    Lutfy K; Cai SX; Woodward RM; Weber E
    Pain; 1997 Mar; 70(1):31-40. PubMed ID: 9106807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.